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ABSTRACT 
Glycemic control is one of the most important aspects of diabetes management and is 
necessary for the prevention or delay of complications associated with diabetes mellitus (DM). 
Self-monitoring of blood glucose (SMBG) is a technique used achieve glycemic control by 
revealing day-to-day changes in blood glucose levels. Since marriage protective effects have 
been shown for mortality, especially for men, it is useful to determine whether a similar 
relationship is found between marriage and SMBG. The purpose of this study is to examine 
whether marital status is a determinant of SMBG, when controlling for other variables, and 
whether marital status determines SMBG differently for males and females.                  
 Demographic data were obtained from 465 individuals who self-reported a diagnosis of 
DM in the continuous NHANES 2009-2010, along with data about treatment, condition, and 
self-management practices. Using logistic regressions, significant predictors were identified for 
SMBG.  
 One-third (36%) of adults with diabetes in the U.S. population do not self-monitor their 
blood glucose level at least 1 time/day. A minority (29.5%) of females who are not married do 
not self-monitor daily, while this is true for nearly half (47.6%) of males who are not married. 
Insulin use is the major determinant for SMBG, along with age, race/ethnicity, and patient DM 
education. Marital status was found to be a significant predictor for SMBG among males, only 
when insulin and pills use were not included in the regression. Marital status was not identified 




 Although marital status is independently associated with reduced mortality, a similar 
protective relationship is not shown between marital status and SMBG. Since SMBG may be a 
useful in the achievement of glycemic control, individuals with diabetes should incorporate this 
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CHAPTER I - INTRODUCTION  
 Diabetes mellitus (DM) refers to a group of diseases that are characterized by 
hyperglycemia as a result of deficiencies with insulin production, alone, or accompanied with 
insulin sensitivity. Approximately 8.3% of the United States (U.S.) population is affected by 
DM, as 18.8 million persons have been diagnosed, while an estimated 7 million persons are 
believed to have undiagnosed DM (Centers for Disease Control and Prevention (CDC), 2011). 
Persistent hyperglycemia is associated with adverse effects on, essentially, every body system 
including cardiovascular disease (CVD), nephropathy, neuropathy, and retinopathy. Such 
complications can ultimately lead to chronic illnesses and death (Shrivastava, Shrivastava, & 
Ramasamy, 2013). However, the prevention or delay of complications associated with DM may 
be achieved with intensive glycemic control (Ohkubo et al., 1995; R. C. Turner, Holman, Cull, & 
Stratton, 1998).  
 The treatment and management of DM is quite complex and meticulous. Furthermore, 
persons with DM or their family members provide 95% or more of the care involved with 
disease management. The self-management of DM consists of: self-monitoring of blood glucose 
(SMBG), tailoring nutrition to daily needs, regular physical activity, and adherence to 
medication regimens in order to achieve adequate glycemic control. Self-management should 
also involve understanding and integrating each component of care in order to make the 
appropriate adjustments according to daily needs (Sigurardóttir, 2005).  
 The two main techniques used to monitor glycemic control include HbA1c testing and 
SMBG, which most often involves using “point of care” devices known as portable glucose 
meters to obtain a small amount of blood from the arm or finger, usually between one and four 
	   2 
times a day, to test the level of blood glucose concentration (Montagnana, Caputo, Giavarina, & 
Lippi, 2009). SMBG is considered the cornerstone of DM management, as it provides relevant 
information that helps achieve glycemic control by reflecting the effectiveness of treatment, 
exposing the potential need for adjustments, and providing information about daily variations of 
glycemic changes that is not available with HbA1c testing. The efficacy of SMBG is 
controversial but has been shown to be associated with improved glycemic control, improved 
health outcomes, and reduced mortality (Martin et al., 2006).  
Despite the debates about the effectiveness of SMBG, the American Association of 
Clinical Endocrinologists (AACE) Diabetes Care Plan Guidelines recommend that individuals 
using insulin should monitor blood glucose at least two times a day or before each injection of 
insulin. However, the recommended frequency for SMBG remains unclear and depends on the 
type of pharmacotherapy used to help achieve target blood glucose levels. Generally, SMBG is 
not required for individuals exclusively taking oral anti-hyperglycemic agents that do not include 
sulfonylureas or glinides to regulate blood glucose, as these agents are less likely to cause 
hypoglycemia. Individuals who rely on insulin therapy should self-monitor blood glucose more 
frequently (Handelsman et al., 2011; Nathan et al., 2009). However, a study investigating the 
frequency of SMBG and its relationship with glycemic control showed that greater than ¼ of 
persons using insulin did not monitor blood glucose level at least once per day. Sixty-five 
percent of the persons using oral agents did not monitor at least one time daily, while most 
individuals treated with diet alone did not monitor glycemic levels (Harris, Cowie, & Howie, 
1993; Harris, 2001). 
 An association between social support and DM self-management behaviors has been 
widely researched, yielding at least minimal evidence of a positive influence. The different types 
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of social support include: family support, peer support, and healthcare provider support with 
further distinctions between structural and functional social support (Chew, Khoo, & Chia, 2011; 
Gao et al., 2013; Strom & Egede, 2012; Tang, Brown, Funnell, & Anderson, 2008). Dunbar-
Jacob and Schlenk (2001) suggest patient adherence as the link between social support and 
improved health. Adherence refers to an individual’s acceptance of illness and the willingness to 
follow through with treatment recommendations and regimens for health maintenance 
(DiMatteo, 2004). Social support may be essential to accomplishing adequate SMBG, in order to 
achieve positive health outcomes. Despite the extensive research about the impact of social 
support on DSM, there is very little evidence about the relationship between marriage and 
SMBG. The existing literature examines the impact of marriage quality, marriage satisfaction, 
and spousal involvement (Trief, Himes, Orendorff, & Weinstock, 2001; Trief, Ploutz-Snyder, 
Britton, & Weinstock, 2004).  
More specifically, it is widely accepted that marital status, a variation of structural social 
support, is associated with longevity and improved health. This trend remains true across 
populations, both globally and in the United States (Hu & Goldman, 1990). However, a recent 
review of prospective studies yields inconsistent findings concerning differentiations among men 
and women, each type of unmarried status (i.e., never married, widowed, and 
divorced/separated), and age groups (Rendall, Weden, Favreault, & Waldron, 2011).  
The purpose of this study is to examine the association between marital status and self-
monitoring of blood glucose. This research aims to answer the following research questions:  
1. What are the determinants of self-monitoring of blood glucose? 
 
2. Is marital status a determinant of self-monitoring of blood glucose when controlling for 
other determinants?	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3. Does marital status determine self-monitoring of blood glucose differently for males and 
females? 
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CHAPTER II – LITERATURE REVIEW 
This chapter contains an overview of the literature regarding the pathophysiology and 
epidemiology of DM. The overview is followed by an exploration of literature addressing self-
monitoring of blood glucose. Lastly, this review will end with a summary of studies that 
investigate the relationship between marital status and mortality.  
TYPES OF DM 
Type 1 Diabetes Mellitus (T1DM) 
There are several different types of DM that are evident by high levels of glucose in the 
blood including type 1, type 2, gestational, and other rare types of diabetes mellitus. Because this 
study mainly focuses on types 1 and 2, there will only be a brief discussion of gestational and the 
other rare types of diabetes mellitus. 
 T1DM is an autoimmune disorder in which an individual’s pancreatic beta cells are destroyed as 
a result of some combination of genetic and environmental interactions. As a result, individuals 
who are diagnosed with T1DM lack the ability to produce the hormone, insulin, which is 
responsible for the regulating the amount of glucose in the blood. The specific combinations of 
environmental and genetic interactions that cause T1DM remain unknown (Gan, Albanese-
O’Neill, & Haller, 2012). Previously known as insulin-dependent diabetes mellitus (IDDM) or 
juvenile diabetes, T1DM is usually diagnosed among children and young adults. This form is 
only found in approximately 5% of all adults diagnosed with DM. Currently, there are no known 
strategies to prevent or cure T1DM (Centers for Disease Control and Prevention (CDC), 2011). 
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As a result, the main goal of treatment is to improve the quality of life among individuals living 
with the disease. In order to prevent or delay complications and sustain survival, individuals with 
T1DM must rely on exogenous insulin therapy, along with the help of healthcare professionals, 
to regulate and control blood glucose levels (Gan et al., 2012). 
Type 2 Diabetes Mellitus (T2DM) 
 T2DM is a metabolic disorder characterized by high levels of glucose in the blood, or 
hyperglycemia, as a result of insulin resistance. This insulin resistance usually occurs before the 
disease develops, occurring when an individual’s body cells do not utilize insulin properly. 
T2DM is usually prefaced by a condition called prediabetes in which blood glucose levels are 
higher than normal but too low for a diagnosis of DM. This evolutionary process from normal 
glucose tolerance to impaired glucose tolerance and eventual T2DM is the result of insulin 
resistance that leads to an eventual defect of insulin production by the pancreatic beta cells.  The 
pancreas is required to produce elevated amounts of insulin in order to regulate blood glucose 
levels and, consequently, is unable to achieve adequate, insulin production that overcomes the 
resistance. T2DM is commonly treated with diet therapy, physical activity, oral anti-
hyperglycemic agents such as Metformin, and insulin therapy (Centers for Disease Control and 
Prevention (CDC), 2011; Simmons, 2010; Surampudi, John-Kalarickal, & Fonseca, 2009).  
As the most common form of diabetes mellitus, T2DM accounts for approximately 90% 
to 95% of all the cases of diabetes mellitus. Formerly known as non-insulin-dependent diabetes 
mellitus (NIDDM) or adult onset diabetes, T2DM has several associating risk factors including 
race/ethnicity, age, and family history of DM, along with the history of gestational diabetes, 
obesity, and sedentary lifestyle. This form of DM is rare among children and young adults but is 
increasingly becoming more prevalent among children and adolescents who are African 
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Americans, American Indians, Asians, and Hispanics/Latin Americans. These races/ethnicities 
are at a greater risk of developing T2DM and its associating consequences (Centers for Disease 
Control and Prevention (CDC), 2011).  
Other Types of Diabetes Mellitus 
 Gestational diabetes mellitus (GDM) is a condition of glucose intolerance that occurs or 
is, initially, identified and diagnosed during pregnancy. African American, Hispanic/Latin 
American, and American Indian women are at a greater risk for developing this form of diabetes 
mellitus. A woman’s risk of developing GDM is enhanced even more with obesity and a family 
history of diabetes mellitus. Treatment is required for blood glucose regulation in order to 
prevent harm in the mother and the infant (Centers for Disease Control and Prevention (CDC), 
2011).  
 GDM, seemingly, occurs as a result of the same pathophysiological processes and 
pathways as with other types of DM that develop outside of pregnancy (type 1 and type 2 DM). 
Therefore, women with GDM have a high risk of developing T2DM after pregnancy. A review 
of longitudinal studies reveal that most women with GDM experience the progression to T2DM, 
but an estimate of only 10% of women are diagnosed soon after delivery (Buchanan & Xiang, 
2005).  
 There are other rare types of DM that are precipitated as a result of particular 
circumstances including surgery, illnesses, infections, pancreatic disease, and taking 
medications. Additionally, specific genetic combinations may trigger the onset of uncommon 
forms, such as maturity-onset DM during youth. There are infrequent forms of DM that may 
occur as a result of gene mutations, neonatal glucose intolerance, and atypical maladies of the 
immune system. These and other rare forms of DM only account for 1% to 5% of all known 
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incidents of DM(Centers for Disease Control and Prevention (CDC), 2011; Mihai, Mihai, 
Cijevschi-Prelipcean, & Lăcătuşu, 2011).  
 DM is a growing epidemic in the U.S. and around the world. Furthermore, the prevalence 
of DM among adults has steadily increased. The prevalence rates are expected to continue 
increasing, due to decreased levels of physical activity and increased rates of obesity. In 2000, 11 
million Americans were diagnosed with DM, yielding a prevalence of 4%. By 2010, there were 
almost 19 million known cases of DM in the U.S., while there is a projection of an increase to 29 
million by the year of 2050 to yield a prevalence of 7.2%, based on emerging trends and 
prevalence data for age-, sex-, and race-specific rates of diagnosed DM from the National Health 
Interview Survey and projected population demography data from the Bureau of Census. Also, 
the rates of DM have remained higher among non-Hispanic African Americans and Mexican-
Americans when compared to non-Hispanic whites (Harris et al., 1998). The projection reveals 
an expectation of the greatest increases appearing among African-American males and females, 
75 years or older (Boyle et al., 2001; Wild, Roglic, Green, Sicree, & King, 2004).  
 The projections of increasing global DM prevalence rates are parallel to that of the U.S. 
Based on a review of studies and prevalence data from 91 countries, the global prevalence of 
DM will reach 7.7% by 2030 with 439 million cases of DM among adults. This is an indication 
of the growing and concerning burden of DM, specifically for developing countries. 
Additionally, these estimates are not based on the projections of obesity and may not provide an 
accurate and lucid depiction of the growing “diabetes mellitus epidemic.” Instead, the number of 
cases of DM worldwide may greatly exceed the projected numbers and pose a larger and more 
dangerous threat to society than is currently expected. Therefore, it is essential to allocate 
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resources and efforts, effectively, in order to reduce the future burden of DM among adults and 
children (Shaw, Sicree, & Zimmet, 2010; Wild et al., 2004).    
COMPLICATIONS ASSOCIATED WITH DM  
 Previous studies show an association between hyperglycemia and microvascular and 
macrovascular complications (Klein, 1995; Pirart, 1978; Standl et al., 1996). Microvascular 
complications refer to nephropathy and chronic kidney disease, sensory neuropathy, amputations 
of the lower extremities, and retinopathy. On the other hand, macrovascular complications 
include chest pain, myocardial infarction, CVD, congestive heart failure, and stroke. Increased 
levels of hyperglycemia are associated with an increased risk of such complications and 
mortality as a result of all causes(Adler et al., 1997; Groeneveld, Petri, Hermans, & Springer, 
1999; R. Turner et al., 1998). The increased risk is, generally, associated with drastically high 
concentrations of blood glucose. Additionally, hyperglycemia, manifested as ranges of 
hemoglobin A1c (HbA1c) between 6% and 11%, is associated with the further development of 
microvascular complications in individuals with T1DM (Diabetes Control and Complications 
Trial Research Group, 1996).  
Some complications associated with DM may be classified as sporadic, as they are 
recurring and require repetitive treatment. For example, an individual with DM may experience 
foot ulcers many times after diagnosis. On the other hand, certain complications are progressive, 
resulting in further damages that yield additional, long-term disabilities. One common example is 
chronic kidney disease that progresses to end-stage renal disease (ESRD). According to data 
from the National Health and Nutrition Examination Survey (NHANES), the prevalence of 
chronic kidney disease, amputations or medical conditions of the feet, and eye damage (all 
microvascular complications) are drastically higher than that of macrovascular complications. 
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Other DM-related complications include reduced resistance to bacterial and viral infections (i.e. 
pneumonia and influenza), dental disease, and the delivery of infants who are large-for-
gestational age, along with other birth complications, among pregnant women (American 
Association of Clinical Endocrinologists, 2007; Deshpande, Harris-Hayes, & Schootman, 2008).  
Whether recurrent or progressive, DM-related complications contribute to the rising 
economic burden of DM and the widespread loss of functionality among individuals with DM. 
By the year 2007, the economic burden of both prediabetes and DM in the U.S. exceeded $215 
billion, as a result of decreased productivity and increased healthcare costs. The average yearly 
cost for each case of T1DM nearly doubles that of T2DM. However, the number of cases of 
T2DM greatly exceeds the number of T1DM cases. Each American has a burden cost, whether 
or not he has been diagnosed with DM, and these alarming, rising costs highlight the importance 
of DM prevention, along with, quality and effective treatment (Dall et al., 2010). 
TREATMENT FOR DM 
Multidisciplinary Team  
 Each individual diagnosed with DM should have a comprehensive treatment plan that 
considers his/her medical history, relevant behavior and risk factors, ethnic and cultural 
background, and environment. A multidisciplinary team is best for the delivery of quality and 
effective care for those with DM. The team should include a primary care physician, 
endocrinologist, and nurse practitioner. The team can also consist of a registered nurse, certified 
diabetes educator, registered dietitian, exercise specialist, and mental health care professional. 
The opportunity to work with an exhaustive team of healthcare providers allows individuals to 
acquire a wealth of knowledge about an array of different topics, addressing their general and 
unique health concerns. Some health care providers are able to devote more time and attention to 
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specific topics that may positively influence health outcomes. According to individuals with 
diabetes mellitus, CDEs often provide more practical education than physicians (Handelsman et 
al., 2011).   
Glycemic and Other Goals   
 The association between hyperglycemia and diabetes mellitus-related microvascular and 
macrovascular complications has been widely accepted. Additionally, efforts and therapies used 
to achieve glycemic control, including intensive insulin therapy, have also been shown to lower 
the rates of microvascular complications and some cardiovascular illnesses associated with DM. 
There are two major methods used to monitor blood glucose levels and achieve glycemic control, 
which includes testing HbA1c levels and the self-monitoring of blood glucose (SMBG). HbA1c 
refers to the proportion of hemoglobin that is a product of glucose saturating erythrocytes 
(glycation), reflecting the mean blood glucose level over 2-4 months since erythrocytes have a 
general life span of 120 days (American Diabetes Association, 2011; Jeffcoate, 2004).  
A review of supporting evidence yields conflicting specific targets for glycemic control. 
The fasting plasma glucose (FPG) of healthy persons does not rise above 99mg/dL or above 120 
mg/dL after meals (Handelsman et al., 2011). Nonetheless, a significant association has been 
shown between T2DM and FPG levels of 87 mg/dL and 94 mg/dL (Hayashino et al., 2007; 
Tirosh et al., 2005). Due to highly varying conditions, glycemic goals should be individualized 
and feasible. Each individual has different amounts of risk factors and comorbidities, along with 
different psychosocial and economic states. According to the AACE, most non-pregnant 
individuals with DM should aim for HbA1c at or below 6.5%, while reducing the risk of 
hypoglycemia as much as possible. Glucose concentrations 2 hours after eating should remain 
less than 140 mg/dL in order to accomplish this glycemic goal, while FPG should remain less 
	   12 
than 110 mg/dL. Individuals with extensive comorbidities, prevalent complications, and severe 
hypoglycemia may require a less restrictive glycemic goal (HbA1c 7% – 8%), as the specific 
goals are much more difficult to achieve despite intensive glycemic control (Handelsman et al., 
2011). On the other hand, the American Diabetes  
The American Diabetes Association (ADA) states that T2DM is diagnosed when the 
fasting plasma glucose level is ≥ 126 mg/dL, the post-prandial plasma glucose level is ≥ 200 
mg/dL, or a random plasma glucose level ≥ 200 mg/dL accompanied by regular symptoms of 
hyperglycemia. The recommended goals from ADA include an HbA1c level of 7%, a pre-
prandial plasma glucose level of 70-130 mg/dL, and a post-prandial plasma glucose level of < 
180 mg/dL(American Diabetes Association, 2011).  
Evidence shows a strong association between previous hyperglycemia and DM-related 
complications, among individuals with T2DM. However, the risk is reduced with any reduction 
in HbA1c.  Each 1% reduction in HbA1c lowers the risk of all DM-related end-points, death, 
myocardial infarction, and microvascular complications. The lowest risk of complications is 
found among individuals with HbA1c below 5.0%(Holman, Paul, Bethel, Matthews, & Neil, 
2008; Khaw et al., 2004; R. C. Turner et al., 1998). Risk factors for CVD should be reduced, as it 
is a primary cause of death among those with DM. In addition, low-density lipoprotein 
cholesterol should remain less than 100 mg/dL, and less than 70 mg/dL for those with CVD or at 
high risk for developing CVD. High-density lipoprotein should exceed 40 mg/dL in men and 50 
mg/dL in women (Handelsman et al., 2011).  
Comprehensive Care Approaches 
 Several strategies may be used to achieve the designated goals and targets for optimal 
health outcomes associated with DM care, including strategic lifestyle changes and 
pharmacotherapy. Registered dietitians/nutritionists or knowledgeable physicians use medical 
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nutrition therapy to develop highly individualized plans that address several topics essential to 
glycemic control and the reduction of risks associated with complications and CVD. The 
dietitian or physician, generally, recommends consistent carbohydrate intake, in addition to an 
insulin dosage that corresponds with a specific carbohydrate intake pattern. This method is often 
referred to as carbohydrate counting. Healthy eating, weight management, adequate protein 
intake, and limitation of high glycemic index foods are also topics of education. Other healthcare 
professionals may also address adequate sleep, cessation and avoidance of tobacco products, and 
stress reduction (Handelsman et al., 2011). 
 Regular physical activity has been shown to improve glycemic control. Despite the 
difficulty of determining the effect of exercise alone, physical activity, including aerobic exercise 
and strength training, contributes to the weight management aspect of DM management when 
coupled with calorie restriction. The suggested 150 minutes per week of moderately intense 
exercise is a widely accepted recommendation. This includes brisk walking and other 
comparable activities. Among those with diabetes mellitus, flexibility and strength training 
activities should also be considered. Professionals should evaluate each individual to determine 
potential restrictions and limitations related to physical activity and help each person develop 
goals and a plan of action to gradually achieve those goals, with an exercise prescription 
(Handelsman et al., 2011).  
 Individuals, using strategies to achieve specific glycemic goals, must take care to reduce 
the risk of hypoglycemia, or low blood glucose, which causes recurring morbidity and occasional 
mortality. For individuals with T2DM, this involves determining the appropriate oral anti-
hyperglycemic agents, as differences exist between the various available agents. Metformin has 
intermediate glycemic control durability (Kahn et al., 2006). However, the addition of a 
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sulfonylurea to Metformin greatly increases the risk of hypoglycemia compared to the use of 
Metformin, alone, or the use of sulfonylurea with thiazolidinedione, another oral anti-
hyperglycemic agent (Belsey & Krishnarajah, 2008). Other agents include dipeptidyl peptidase 4 
inhibitors and bromocriptine mesylate, which are not associated with an increased risk of 
hypoglycemia. Practitioners should also consider whether the FPG or postprandial glucose is the 
main target, while considering the common adverse effects associated with each oral agent, in 
order to determine the best selection for each individual (Handelsman et al., 2011).  
 For individuals with DM, the use of any type of insulin therapy increases the complexity 
of disease management. Insulin is required for all individuals with T1DM, while insulin therapy 
should also be considered for individuals with T2DM, particularly those who have not achieved 
glycemic control with oral anti-hyperglycemic agents, alone. A physiologic insulin regimen 
providing basal and prandial insulin, such as multiple daily injections (MDI) or continuous 
subcutaneous insulin infusion (CSII) is recommended. MDI refers to one or more basal insulin 
injections to regulate blood glucose levels overnight and between meals, in addition to prandial 
insulin injections before each meal to regulate blood glucose levels related to eating. MDI 
regimen, often, yields episodes of hypoglycemia, especially among individuals who experience 
difficulty with adherence to the regimen. CSII, also known as insulin pump therapy, refers to the 
continuous infusion of short-acting insulin delivered under the skin. It is particularly useful for 
those with T1DM who are ambitious and well educated about DM management. Success with 
CSII requires extensive education, several reevaluations, and a knowledgeable practitioner or 
physician (Handelsman et al., 2011).  
 Additionally, insulin analogues may be used to achieve glycemic control. Premixed 
insulin is available in combinations of 70% intermediate-acting insulin and 30% regular acting 
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insulin, providing blood glucose regulation between meals and after meals. The dosage of 
premixed insulin regimen is not flexible, as the injection doses cannot be changed. Premixed 
insulin therapy is not always successful in achieving glycemic goals and requires increased doses 
or frequency. However, hypoglycemia and weight gain are adverse consequences of such 
increases.  
Instead, basal-bolus insulin therapy provides more flexibility and is useful for individuals 
with irregular mealtimes. This regimen involves 4 daily injections that provide basal and prandial 
insulin. The dosage of insulin depends on body weight, level of insulin resistance, and the 
amount of carbohydrate consumption at each meal. Adjustments to each basal and prandial 
dosage should be made to achieve glycemic control, while reducing the risk of hypoglycemia 
(Handelsman et al., 2011).   
Diabetes Self-Management  
 The high rate of morbidity and complications associated with DM can be delayed and 
prevented by achieving and maintaining glycemic control with appropriate DM self-management 
(Ohkubo et al., 1995; R. C. Turner et al., 1998). Diabetes self-management (DSM) behaviors 
include healthy eating (including limiting high fat foods and caloric restrictions for overweight 
and obese individuals), physical activity, SMBG, and foot care (Shrivastava et al., 2013). Self-
management of DM should also consist of acknowledging and treating symptoms related to DM, 
seeking appropriate medical care for specific health problems, and engaging in behaviors that 
reduce the risk of developing further complications and comorbidities (Glasgow & Strycker, 
2000; Goodall & Halford, 1991; Shrivastava et al., 2013). Previous studies that explore effective 
DSM reveal adequate health professional advice (Agborsangaya et al., 2013; Sigurardóttir, 
2005). Other determining elements include family behavior among older Mexican Americans 
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and influences of spirituality, stress, and multi-caregiving responsibilities among African-
American women (Samuel-Hodge et al., 2000; Wen, Shepherd, & Parchman, 2003).  
SELF-MONITORING OF BLOOD GLUCOSE (SMBG)  
 Glycemic control and individual blood glucose targets can be achieved with 
comprehensive care and effective DSM. According to the ADA, daily blood glucose values 
generate reliable information that may aid with adjusting treatment regimens and insulin doses. 
SMBG provides more useful information about daily (Nathan et al., 2009). When used properly, 
SMBG is an essential component of modern DM management and a source of meaningful 
clinical data that can contribute to adequate glycemic control and positive health outcomes. 
Regarded as the cornerstone of DM management, SMBG is especially useful among individuals 
with T1DM, those receiving insulin therapy, and those with a history of asymptomatic 
hypoglycemia (Nathan et al., 2009). A more recently developed method of SMBG involves 
wearing a continuing glucose monitoring system that is known to detect glycemic variations that 
are often missed with the conventional method of SMBG, potentially changing the course of DM 
management in the future (Boland et al., 2001). 
SMBG is used to achieve and maintain glycemic control, expose problems with DM 
management, identify and prevent hypoglycemia and severe hyperglycemia, increase motivation 
among individuals with DM, and improve the individual’s understanding of DM and its 
management (Karter et al., 2001; Walford, Gale, Allison, & Tattersall, 1978). A review of 
studies shows a greater reduction in HbA1c when SMBG is included in a multi-component 
treatment regimen than in those that do not include it. However, findings from a different study 
show no relationship between HbA1c and SMBG among participants (Davis, Bruce, & Davis, 
2006). Additionally, a systematic review of studies shows an inadequate level of effectiveness of 
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SMBG on glycemic control. Researchers propose that improvements in glycemic control as a 
result of SMBG occur only in the context of appropriate education among persons with DM and 
their healthcare providers (Clar, Barnard, Cummins, Royle, & Waugh, 2010). Epidemiologic 
data, on the other hand, suggests an association between SMBG and reduced rates of DM-related 
morbidity and all-cause mortality among persons with T2DM, regardless of the type of 
pharmacotherapy (Martin et al., 2006). Although, studies reveal at least minimal evidence of an 
association between SMBG and improved glycemic control and health outcomes, evidence 
shows a lack of adherence to SMBG among Americans with DM. By investigating the 
relationship between glycemic control and SMBG among individuals with DM in the U.S. 
population, researchers found that greater than twenty-five percent of those using insulin did not 
monitor blood glucose level at least once per day. Sixty-five percent of the persons using oral 
agents did not monitor at least one time daily, while most individuals treated with diet alone did 
not monitor glycemic levels (Harris et al., 1993; Harris, 2001).  
There is much debate about the effectiveness of SMBG among individuals with T2DM 
who are not using insulin. Individuals using oral anti-hyperglycemic agents and/or diet, 
exclusively, are encouraged to use SMBG to determine success with achieving target blood 
glucose values and the possible need for treatment adjustments. However, several researchers 
argue that the use of SMBG among individuals not using insulin should be considered in the 
context of cost and inconvenience, suggesting that SMBG may be clinically beneficial but not 
cost-effective or the best use of time.  Structure and education are identified as essential 
components to the success of SMBG among these persons. Other outcomes, such as quality of 
life and patient satisfaction, are also recognized as determinants of effective SMBG in those not 
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using insulin (Cameron, Coyle, Ur, & Klarenbach, 2010; Polonsky & Fisher, 2013; Welschen et 
al., 2005). 
 Several studies that explore the factors influencing the frequency of SMBG among 
individuals with DM in the U.S. reveal significant predictors of SMBG. Using cross-sectional 
and longitudinal data, along with multivariate and linear regression models, findings indicate 
significant associations between SMBG and several determinants including the duration of the 
disease, insulin use, age, gender, race/ethnicity, education, English-communication ability, 
smoking status, and alcohol consumption. Other determinants of SMBG include whether persons 
have had a DM education class and the frequency of physician visits for DM care, specifically 
(Harris et al., 1993; Karter, Ferrara, Darbinian, Ackerson, & Selby, 2000). SMBG is less 
frequent among older individuals, those with lower neighborhood socioeconomic status, and 
those who have had fewer HbA1c tests and physician visits (Adams et al., 2003). Additionally, 
the frequency of SMBG has been shown to decrease with increasing age for individuals with 
T2DM (Evans et al., 1999). When compared to non-Hispanic whites and Mexican Americans, 
African Americans are 60% less likely to monitor their blood glucose at least once a day. In 
comparison to those with lower education levels, individuals with a college education are 80% 
more likely to monitor their blood glucose levels at least once a day (Harris et al., 1993). 
 Evidence suggests that all types of social support have a positive influence on improving 
DM self-management behaviors including adherence to treatment recommendations, nutritional 
selections, and physically active lifestyles. Additionally, social support has been shown to be 
positively associated with the improved ability to make healthcare decisions, enhanced 
psychosocial health, and less mortality (Chew et al., 2011; Gao et al., 2013; Strom & Egede, 
2012; Tang et al., 2008).  
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Despite the extensive research about social support and its impact on DM self-
management, there is little existing literature that addresses the impact of marriage. Previous 
studies that have examined the relationship between marriage and DM management investigate 
marriage quality and satisfaction (Trief et al., 2001; Trief et al., 2004). Moreover, to my 
knowledge, no previous study has extensively explored the association between marital status 
and SMBG, investigating differences between male and female and each category of marital 
status (single, married, divorced, separated, widowed, never married).  
It has been long accepted that marriage is associated with lower rates of mortality and 
better health outcomes(Hu & Goldman, 1990). Kaplan and Kronick (2006) explored the 
relationship between marital status and all-cause mortality, along with cause-specific mortality, 
using data from the US national health interview survey and the national death index. The six 
categories of specific causes of death included infectious disease, cancer, cardiovascular disease, 
pulmonary disease, external causes such as homicides/suicides and accidents, and all “other” 
causes. By estimating the association with multivariate logistic regressions, findings showed that 
individuals who were never married had a greater risk of all-cause mortality (OR=1.58, CI 1.39 
to 1.78) than those who were divorced or separated (OR=1.27) and widowed (OR=1.39). The 
researchers referred to this manifestation as the “never-married penalty.” In addition to marital 
status, age was the strongest predictor of mortality, along with other determinants such as 
gender, income, race/ethnicity, and disability status. Also, those who were never married were 
over four times more likely to die as a result of infectious diseases. Being never married was a 
greater risk factor for the remaining causes of death excluding CVD, cancer, and pulmonary 
disease. This evidence contradicts the findings of several other studies, which indicate the 
divorced/separated or widowed statuses as the greatest risk factors of mortality among all marital 
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states. However, it is difficult to draw conclusions of a causal relationship between marriage and 
lower mortality, or a protective effect of marriage, from cross-sectional data.  An alternate 
conclusion addresses the potential concept of positive selection of healthier and wealthier 
individuals into marriage (Goldman, 1993). Yet, the protective effect of marriage remains 
evident after controlling for characteristics such as income, education, and health, which are 
believed to select individuals into marriage (Espinosa & Evans, 2008). Prospective data sets that 
reflect the individual-level are superior, yielding stronger evidence than that of cross-sectional 
data. However, studies that investigate mortality differences between men and women and the 
different unmarried statuses using individual-level, prospective data reveal inconsistent findings 
that identify the marriage protective effect for men and women (Lillard & Waite, 1995) or for 
men only (Zick & Smith, 1991), while there was no difference found between genders for old-
age mortality (Manzoli, Villari, Pirone, & Boccia, 2007).  
Rendall et al. (2011) propose two potential sources of the inconsistent findings, including 
the use of baseline, covariate data sets that do not appropriately reflect the time of exposure to 
mortality and the inappropriate use of statistical tests, failing to perform proper between group 
statistical analyses. As a result, they planned to resolve these inconsistent findings by using time-
varying data from the U.S. Survey of Income and Program Participation and logistic regression 
models to estimate the yearly probability of death. The predictor variables included age, calendar 
year, race/ethnicity, educational attainment, working status, income earnings, and disability 
status. Also, statistical tests were performed to determine differences between the married and 
unmarried status, in addition to determining differences between ages, gender, and each 
unmarried status (never married, divorced/separated, and widowed). The findings showed strong, 
significant associations between being married and a lower probability of death among 
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individuals ages 25-64 which decreased after controlling for socio-demographic characteristics 
that changed over time. The protective effects of marriage disappeared at older ages for both men 
(89 years) and women (84 years). Additionally, the survival benefit of marriage was lower for 
women than for men, but this occurrence decreased with age. There was no difference found 
between unmarried statuses among individuals who were 25 years of age, excluding an existing 
difference between divorced/separated men and widowed individuals. However, a greater risk of 
mortality into older age was found for divorced/separated men and women than that of men and 
women older than 25 years, who were never married or widowed. Similar results were found for 
divorced and separated men and women ages 65 and older. These findings support both proposed 
interpretations of a consistent protective effect of marriage that decreases with age and the 
selection of individuals into marriage, due to socio-demographic characteristics. Lastly, the 
findings give weak evidence of mortality differences between each unmarried status.  
Summary 
 The growing prevalence of DM, in the U.S. and worldwide, and its associating 
complications have increased the economic burden, and the projected cost is expected to 
continue rising at an alarming rate. The treatment goal for individuals with DM is to achieve and 
maintain strict glycemic control, which often consists of a complex regimen. DM self-
management, including SMBG, eating a healthy diet, being physically active, and taking 
medications appropriately, constitutes a large proportion of DM care. SMBG, the cornerstone of 
DM management, provides essential information for successfully achieving and maintaining 
glycemic control. The efficacy of SMBG is controversial, particularly among those not using 
insulin, but has been shown to improve individuals’ level of understanding and glycemic control 
and is highly recommended by healthcare providers. Despite the evidence of its benefits, there is 
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a lack of SMBG among individuals with diabetes mellitus, especially older adults and African 
Americans. Social support has been identified as a determinant of DM self-management, 
including SMBG, but there is very little existing literature that addresses the relationship 
between marriage and SMBG. Marriage, a type of structural social support, is associated with 
less mortality, with an additional survival advantage seen among men. There is inconsistent 
evidence regarding mortality differences between men and women and the different categories of 
the unmarried state (never married, divorced/separated, and widowed). Exploring an association 
between marital status and SMBG may provide more information about methods used to 
improve self-management among individuals with DM.  
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CHAPTER III - RESEARCH DESIGN AND METHODS 
	  
The National Health and Nutrition Examination Survey (NHANES) is a population-
based, survey designed to collect data regarding the health and nutrition of non-institutionalized 
adults and children in the United States (U.S.). The survey is conducted by the National Center 
for Health Statistics (NCHS) as a part of the Centers for Disease Control (CDC). The NHANES 
is exceptional, as it is a national survey that assesses health and nutritional information using 
both face-to-face interviews and physical examinations. Each participant is involved in a home 
interview about health, disease history, and diet, while the clinical examination involves medical 
and physiological measurements in addition to laboratory tests. HbA1c, which is used to reflect 
the plasma glucose levels over the past 120 days, was one of the laboratory tests measured 
during the separate clinical examination, along with body mass index (BMI). Self-reported data, 
laboratory data, and clinical data are obtained from a representative sample of U.S. children and 
adults.  
Cross-sectional data from the continuous NHANES 2009-2010 were analyzed to identify 
determinants for SMBG among participants with DM. More recent data has been released, but at 
the time of this study NHANES 2009-2010 was the most recent dataset released in its entirety. 
Analyses were conducted to determine whether marital status is a significant predictor of SMBG 
behavior and to examine whether marital status determines SMBG differently for males than for 
females.  
The continuous NHANES 2009-2010 had a sample of 10,537 participants.  The sample 
for this study was reduced to 739 participants, who reported having received a diagnosis of DM 
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by a doctor or health professional. Those who were under 20 years of age were excluded from 
the sample, yielding 725 participants. Also, two participants who refused to provide marital 
status data were excluded. Those whose income and BMI data were missing were also excluded, 
leaving a remainder of 668 participants. Since age is top coded at 80 years, all participants who 
were 80 years and older were excluded (69 participants). Additionally, participants who reported 
“I don’t know” as a response for age at diagnosis, along with those with missing treatment and 
DM education data were excluded (131 participants). Lastly, those with missing education, 
HbA1c, and SMBG data were excluded. The remaining 465 participants were included in the 
analysis. IRB approval was not required due to the use of secondary data with no identifiers.  
Measures  
	   Variables were strategically extracted from the core survey by isolating a group of 
questions that addressed DM including diagnosis, medical care, and self-management practices. 
The extracted variables can be divided into two main components: a screening question to 
identify all individuals with DM and detailed questions about the participants’ condition. Also, 
demographic data were extracted from the core survey, including marital status. Additionally, the 
two variables extracted from the clinical examination were HbA1c and BMI. Duration of DM 
was determined by subtracting the age at diagnosis from the age at the time of screening. The 
frequency of self-monitoring of blood glucose (SMBG), the dependent variable, was determined 
by the participants’ responses to the question, “How often do you check your blood for glucose 
or sugar? Include times when checked by a family member or friend, but do not include times 
when checked by a doctor or other health professional.” Each SMBG response was transformed 
to reflect an annual unit of measure. Then, the variable was dichotomized into the derived 
variable, checks daily, where ≥ 365 = 1 and < 365 = 0. This method was validated by comparing 
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the number of participants (297/63.87%) who reported self-monitoring their blood glucose ≥ 1 
time per day to the number of those (299/64.3%) with ≥ 365 as a response for checks daily, 
which resulted in a correlation of 0.9933126. 
Statistical Analyses 
Binary logistic regression analyses were used to identify the determinants of SMBG, 
among those with DM. First, marital status, age, race/ethnicity, education, income, DM 
education, and duration of diabetes variables were included in the regression as explanatory 
variables for all participants. Then, additional covariates of HbA1c, taking insulin, and taking 
anti-hyperglycemic pills were entered into the regression, along with the previously mentioned 
covariates, to examine whether the determinants change when controlling for DM conditions. In 
addition, logistic regressions were run in the same manner as mentioned above for females and 
males, separately, in order to examine whether marital status determines SMBG differently for 
men and women. Statistical significance was defined as P < .05, using a one-tailed test. SPSS 
Statistics 20.0 was used to perform the statistical analysis.  
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CHAPTER IV- RESULTS 
Sample Characteristics 
The characteristics of the 465 participants with diabetes in the sample are summarized in 
Table 1. Almost half (41.7%) of the participants were ≥ 65 years of age, 48% were males, and 
34.2% were non-Hispanic white. About a quarter (24.5%) of the participants had a household 
income under $20,000. The majority of the participants were currently married or living with a 
partner (60.0%) and had a high school diploma/GED or greater (62.6%). The mean duration of 
their diabetes was nearly 12 years (11.7 ±11.0), with a large variance. Over half of the 
participants (54.2%) had an HbA1c ≤ 7, and the mean BMI was 33.7 ± 8.3. Nearly half of the 
participants (47.5%) had seen a nurse educator or dietitian not more than a year ago for diabetes 
education. Also, 79.4% and 29.9% of the participants reported taking anti-hyperglycemic pills 
and insulin, respectively, to lower blood glucose.  
Self-monitoring of Blood Glucose (SMBG) According to Marital Status and Gender 
Table 2 presents the percentage of participants who self-monitor their blood glucose 
levels daily. Sixty-four percent of the sample checked their blood glucose level at least one time 
a day, regardless of marital status.  Of all the male participants, 60.7% checked their blood 
glucose level daily, while 64% of males who were currently married/living with a partner and 
52% of those who were not married checked daily. Of all the female participants, 67.6% checked 
their blood glucose level daily, while 64.7% of females who were married/living with a partner 
and 70.5% of those who were not married checked daily. Marriage is shown to have different 
implications for male and female participants, as it seems to have positive effect on 
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SMBG behavior among males but not females. Logistic regression analyses establish whether or 
not this is a mere coincidence.  
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Table 1. Characteristics of the sample (n=465) 
Characteristics n (%) Mean ±  SD 
Age, y   
      24-34 21 (4.5)  
      35-44 30 (6.5)  
      45-54 78 (16.8)  
      55-64 142 (30.5)  
      ≥ 65 194 (41.7)  
Male  224 (48.2)  
Race   
      Mexican American  99 (21.3)  
      Black 120 (25.8)  
      White 159 (34.2)  
      Other Hispanic 57 (12.3)  
      Other Race, including Multi-Racial  30 (6.5)  
Education Level   
      No High School Diploma 174 (37.4)  
      High School Diploma/GED or Equivalent 92 (19.8)  
      Associate’s Degree/Some College 134 (28.8)  
      College Graduate or Above  65 (14.0)  
Income   
       Under $20,000 114 (24.5)  
       Over $20,000 33 (7.1)  
       $20,000 to $44,999 154 (33.1)  
       $45,000 to $74,999 92 (19.8)  
       $75,000 to Over  72 (15.5)  
Marital Status   
        Married/Living with a Partner 280 (60.2)  
        Widowed  63 (13.5)  
        Divorced/Separated 86 (18.5)  
        Never Married 36 (7.7)  
BMI  33.7 ± 8.3 
Duration of Diabetes, y  11.7 ±11.0 
Education from Diabetes Specialist   
        1 year ago or less 221 (47.5)  
        1 to 5 years ago 78 (16.8)  
        More than 5 years ago 37 (8.0)  
        Never 129 (27.7)  
HbA1c   
        7 or Less  252 (54.2)  
        Greater than 7 213 (45.8)  
Treatment    
        Pills 369 (79.4)  
        Insulin  139 (29.9)  
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All 64.3 60.7 67.6 
Married 64.3 64.0 64.7 
Not Married 64.3 52.4 70.5 
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Key Determinants of Self-monitoring of Blood Glucose 
The results from the binary logistic regression analyses are presented in Table 3. In the 
shorter logistic regression, demographics including marital status, along with duration of 
diabetes and diabetes education from a nurse educator or dietitian were entered. When the 
regression was performed for entire sample, age ≥ 65 (OR = 1.9, P = .016), non-Hispanic white 
(OR = 3.4, P = < .001), diabetes education 1 year ago or less (OR = 1.7, P = .023), and duration 
of diabetes (OR = 1.0, P < .001) were significant predictors of SMBG. When HbA1c, taking 
insulin, and taking pills were added to the regression, age ≥ 65 (OR = 2.5, P = .003), non-
Hispanic white (OR = 3.1, P = < .001), and diabetes education 1 year ago or less (OR = 1.6, P = 
.044) remained significant predictors of SMBG, along with taking insulin (OR = 6.5, P = < .001) 
and taking pills (OR = 1.8, P = .034). However, duration of diabetes was no longer statistically 
significant (OR = 1.0, P = .208). Marital status was not shown to be a significant predictor of 
SMBG (OR = 1.0, P = .432). 
When the shorter regression was performed for females only, age 55-64 (OR = 0.8, P = 
.031) and age ≥ 65 (OR = 1.0, P = .006)	  were significant predictors of SMBG. Also, non-
Hispanic white participants were 7 times as likely as Mexican-American participants to monitor 
their blood glucose level (OR = 7.0, P = .036).	  Duration of diabetes was, also, a significant 
predictor (OR = 1.1, P = .011). However, statistical significance did not hold for non-Hispanic 
white (OR = 1.7, P = .125) and duration of diabetes (OR = .77, P = .236) when HbA1c, taking 
insulin, and taking pills were added to the regression.  Age 55-64 (OR = 1.8, P = .010) and age ≥ 
65 (OR = 3.3, P = .004)	  remained as statistically significant predictors of SMBG. Female 
participants who were taking insulin were greater than 22 times more likely to monitor their 
blood glucose level daily (OR = 22.3, P = < .001)	  and those taking pills were more than twice as
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likely to self-monitor blood glucose (OR = 2.6, P = .033). The regression did not show marital 
status as a significant predictor of SMBG among female participants (OR = 0.8, P = .214).  
The binary logistic regression was also performed for males only. The shorter regression 
revealed currently married/living with a partner as a significant predictor. Participants who were 
currently married/living with a partner were nearly twice as likely as those who were unmarried 
to self-monitor their blood glucose level at least one time a day (OR =1.9, P = .031).	  Non-
Hispanic white (OR = 7.0, P = < .001), non-Hispanic black (OR = 3.1, P = .008), and duration of 
diabetes (OR = 1.1, P = .001) were statistically significant predictors, also. However, statistical 
significance for currently married/living with a partner did not hold when HbA1c, taking insulin, 
and taking pills were added to the regression (OR = 1.7, P = .072). Non-Hispanic white (OR = 
7.6, P = < .001), non-Hispanic black (OR = 3.4, P = .007), and other race, including multi-racial 
(OR = 3.6, P = .048) were significant predictors. Also, the male participants who were taking 
insulin were nearly 5 times as likely to self-monitor their blood glucose level daily (OR = 4.8, P 
= < .001).  
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Table 3. Odds of Predicting Daily Self-monitoring of Blood Glucose 
 
All 
(n = 465) 
All 
(n = 465) 
Females 
(n = 241) 
Females 
(n = 241) 
Males 
(n = 224) 
Males 














Married  1.0 .437 .96 .432 .75 .181 .76 .214 1.9* .031 1.7 .072 
Age, y              
       24-34 1.1 .449 .85 .396 1.6 .268 .71 .352 .62 .273 .65 .310 
       35-44 1.4 .223 1.5 .212 1.7 .210 1.1 .448 1.1 .432 1.6 .283 
       45-54 (omitted)             
       55-64 1.4 .119 1.4 .148 2.3* .031 1.8* .010 .84 .357 .91 .432 
       ≥ 65 1.9* .016 2.5* .003 2.9* .006 3.3* .004 .97 .479 1.3 .285 
Race              
       Mexican American (omitted)             
       Other Hispanic 1.0 .466 1.0 .474 .96 .475 .75 .299 1.3 .310 1.6 .223 
       Non-Hispanic White 3.4* < .001 3.1* < .001 2.2* .036 1.7 .125 7.0* < .001 7.6* < .001 
       Non-Hispanic Black  1.7 .051 1.6 .063 .97 .476 .78 .293 3.1* .008 3.4* .007 
       Other incl. Multi-racial 1.8 .111 1.9 .099 1.3 .335 1.2 .405 2.8 .069 3.6* .048 
Education              
       No High School Diploma 1.4 .144 1.3 .194 1.1 .407 .91 .425 1.6 .162 1.5 .187 
       High School Diploma/GED (omitted)             
       Some College/Assoc.’s Degree 1.1 .408 .87 .333 1.1 .421 .70 .233 .84 .354 .73 .263 
       Bachelor’s Degree or Greater 1.1 .368 1.1 .434 1.4 .274 1.3 .329 .75 .296 .74 .295 
Income             
       Under $20,000 1.4 .112 1.4 .109 1.2 .329 1.2 .335 1.3 .257 1.3 .271 
       ≥ $20,000 (omitted)              
Education from Diabetes Specialist             
       1 year ago or less 1.7* .023 1.6* .044 1.6 .109 1.4 .179 1.8 .059 1.8 .071 
       1 to 5 years ago 1.3 .215 1.3 .204 1.3 .255 1.5 .210 1.1 .444 1.1 .456 
       More than 5 years ago 0.9 .413 .73 .246 .64 .231 .47 .128 1.5 .276 1.2 .403 
       Never (omitted)             
Duration of Diabetes, y 1.0* < .001 1.0 .208 1.0* .011 1.0 .413 1.1* .001 1.0 .128 
HbA1c ≤ 7   .81 .197   .77 .236   .81 .280 
HbA1c > 7 (omitted) 
            
Treatment 
            
         Insulin   6.5* < .001   22.3* < .001   4.8* < .001 
         Pills   1.8* .034   2.6* .033   1.96 .083 
-2 Log likelihood 549.454 509.954 275.863 244.399 256.592 241.400 
Notes: Data come from the continuous National Health and Nutrition Examination Survey (NHANES) 2009 – 2010. The sample consists of adults (ages 20-79) with diabetes mellitus in the U.S. 
population.  
*P < .05 
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CHAPTER V - DISCUSSION 
This data indicates that approximately one-third (36%) of adults with diabetes in the U.S. 
population do not self-monitor their blood glucose level at least 1 time/day. Additionally, 32% 
females and 39% of males with diabetes do not self-monitor 1 time/day. More specifically, 
29.5% of females who are not married do not self-monitor daily, and this is true for an even 
greater number (47.6%) of males who are not married. The results of this study mirror that of a 
previous national study of SMBG, revealing the use of insulin as a major determinant, especially 
among females (Harris et al., 1993).  
Besides insulin use, there were other significant predictors of daily SMBG including age, 
race/ethnicity, and DM patient education. Among all participants, those who were ≥ 65 years 
were twice as likely to self-monitor daily than those who were ages 24-34. This differs from the 
findings of previous studies, which show a trend of decreasing odds of SMBG with increasing 
age (Evans et al., 1999; Harris et al., 1993). Non-Hispanic whites were 3 times more likely to 
self-monitor 1 time/day compared with Mexican Americans. Also, those who had patient DM 
education from a nurse educator or dietitian within the past 12 months were nearly twice as 
likely to self-monitor daily than those who never received patient DM education. The 
significance of the variable, duration of diabetes, did not sustain after controlling for the types of 
treatment including the use of insulin and oral anti-hyperglycemic pills. Also, income and 
education were not significantly related to daily SMBG.  
Marriage has been shown to have protective effects as it relates to health and mortality. It 
is the belief that marriage protects against death through emphasis on health, risk reduction, and 
compliance with medical regimens (Rogers, 1995). Married persons have been shown to have 
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lower risks of death compared to non-married persons, even after adjusting for additional 
socioeconomic variables (Johnson, Backlund, Sorlie, & Loveless, 2000). Since SMBG is a 
technique or regimen used by individuals with diabetes to prevent or delay morbidity and 
mortality, it is useful to examine the relationship between marital status and SMBG. However, 
marriage was independently related to SMBG for males only, when the use of insulin and pills 
were not included in the logistic regression. Moreover, the significance for marriage as a 
predictor among males was dissolved after controlling for the use of insulin and anti-
hyperglycemic pills (P = .072).  Marital status was not shown to be a significant predictor of 
SMBG in females or any other instance.  
Men and women are believed to have vast mortality differences as it relates to marital 
status. Some studies report marriage protection for males and females (Lillard & Waite, 1995), 
females only (Zick & Smith, 1991), and no difference for old-age mortality (Manzoli et al., 
2007). Another study reports marriage protection and marriage selection effects for women who 
were not employed full-time (Waldron, Hughes, & Brooks, 1996). Also, divorced men have been 
shown to have the highest death rates among unmarried groups (Hu & Goldman, 1990). 
However, it has been suggested that gender mortality differences, as they relate to marital status, 
become smaller when employment and number of children are considered (Hemström, 1996). In 
order to examine the differences between males and females, the relationship between several 
predictors and daily SMBG was analyzed, separately, for each gender. Age was independently 
related to SMBG among females, along with using insulin and taking anti-hyperglycemic pills. 
Among males, however, race and insulin use were significant predictors of SMBG.  
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Implications 
The ultimate goal of SMBG is to achieve optimal glycemic control and prevent 
complications and mortality associated with DM. Since hyperglycemia and poor glycemic 
control is associated with several diabetes-related complications, such as retinopathy, 
neuropathy, and nephropathy, achieving glycemic control is the single most important aspect of 
disease management for individuals with diabetes. SMBG is used to help achieve glycemic 
control by providing knowledge of day-to-day glycemic ranges and illuminating problems with 
treatment. Also, the prevention or delay of further complications contributes to cost-savings, as 
costly conditions such as blindness and end-stage renal disease (ESRD) often occur as a result of 
poorly controlled diabetes. Physicians, nutrition practitioners, and diabetes nurse educators 
should continue to place emphasis on the use of SMBG, especially among younger adults, those 
who have not received DM education within the past year, and those who do not use insulin. 
Study Limitations 
In this continuous NHANES data 2009-2010, it was not possible to differentiate between 
those with T1DM and T2DM. Analyzing this data by the type of diabetes may reveal more 
useful findings. Additionally, this study does not examine the relationship between SMBG and 
glycemic control and, therefore, does not address whether those who self-monitor daily have 
better glycemic control than those who do not self-monitor. Likewise, this study does not address 
whether marital status determines glycemic control differently for males and females. These 
topics should be the focus of future research.  
Conclusions  
 In conclusion, one-third of the U.S. adults with diabetes do not self-monitor blood 
glucose at least 1 time/day. Insulin is the main predictor of daily SMBG, while the odds of daily 
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SMBG increase with age. Other significant predictors of SMBG are race/ethnicity and patient 
DM education. There are differences among determinants of SMBG for males and females. 
While age, race, insulin use, and taking anti-hyperglycemic pills determine SMBG for females, 
only race and insulin use determine SMBG for males. Although marital status is independently 
associated with reduced mortality, a similar protective relationship is not shown between marital 
status and SMBG. Since SMBG may be useful in the achievement of glycemic control, 
individuals with diabetes should incorporate this practice into their regimens for diabetes self-
management.  
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